Since the first description of RA-specific antibodies to citrullinated peptides, several citrullinated proteins have been proposed as physiological targets for ACPA specificity, such as fibrin [2], Epstein-Bar virus nuclear antigen [3], α-enolase [4] and vimentin [5]. This evidence concerns the gene VIM and rheumatoid arthritis.